Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines
- PMID: 20029174
- DOI: 10.1159/000268855
Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines
Abstract
Background/objective: The management of chronic childhood idiopathic thrombocytopenic purpura (ITP) is distinct from acute ITP. Similar to the publication on acute ITP guidelines, the AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) considered it appropriate to develop consensus guidelines for chronic childhood ITP to provide useful and shared information for physicians, healthcare professionals, parents and patients.
Design/methods: A preliminary, evidence-based document issued by a select group of AIEOP pediatric hematologists was discussed, modified and approved during a Consensus Conference according to procedures previously validated by the AIEOP Board.
Results: The guidelines give prominence to the periodical reevaluation of all the etiological hypotheses of thrombocytopenia in relation to its clinical condition. The majority of chronic ITP children do not require treatment, especially if bleeding is absent or minimal. The treatment decision depends on several factors other than the platelet count, and treatment options are suggested in relation to the therapeutic scenarios. Recommendations are given regarding support for surgery, particular hemorrhagic conditions, daily activities/sports, as well as for vaccines and drugs. Experimental treatments are also discussed.
Copyright 2009 S. Karger AG, Basel.
Similar articles
-
Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica.Haematologica. 2000 Apr;85(4):420-4. Haematologica. 2000. PMID: 10756369 Review.
-
Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.Acta Haematol. 2006;115(1-2):46-52. doi: 10.1159/000089465. Acta Haematol. 2006. PMID: 16424649 Clinical Trial.
-
Management of adult idiopathic thrombocytopenic purpura.Clin Adv Hematol Oncol. 2006 Feb;4(2):136-44, 153. Clin Adv Hematol Oncol. 2006. PMID: 16728922 Review.
-
Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience.Acta Haematol. 2008;119(1):1-7. doi: 10.1159/000112837. Epub 2008 Jan 4. Acta Haematol. 2008. PMID: 18176072
-
Management of chronic immune thrombocytopenic purpura in children and adults.Semin Hematol. 1998 Jan;35(1 Suppl 1):36-51. Semin Hematol. 1998. PMID: 9523748 Review.
Cited by
-
B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy.Pediatr Res. 2016 Feb;79(2):262-70. doi: 10.1038/pr.2015.211. Epub 2015 Oct 22. Pediatr Res. 2016. PMID: 26492283
-
Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP.Blood Adv. 2021 Mar 23;5(6):1617-1626. doi: 10.1182/bloodadvances.2020003004. Blood Adv. 2021. PMID: 33710335 Free PMC article.
-
Management of colorectal cancer liver metastasis in a patient with immune thrombocytopaenia.Ann R Coll Surg Engl. 2013 Mar;95(2):e50-1. doi: 10.1308/003588413X13511609957498. Ann R Coll Surg Engl. 2013. PMID: 23484984 Free PMC article.
-
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura.Haematologica. 2011 Dec;96(12):1883-5. doi: 10.3324/haematol.2011.045732. Epub 2011 Aug 9. Haematologica. 2011. PMID: 21828121 Free PMC article. Clinical Trial.
-
Efficacy of combined intravenous immunoglobulins and steroids in children with primary immune thrombocytopenia and persistent bleeding symptoms.Blood Transfus. 2014 Jul;12(3):340-5. doi: 10.2450/2014.0185-13. Epub 2014 Mar 3. Blood Transfus. 2014. PMID: 24887226 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources